Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1879 1
1888 1
1893 1
1902 1
1954 1
1964 2
1965 2
1966 1
1967 1
1969 3
1970 3
1971 1
1972 8
1973 5
1974 7
1975 1
1976 10
1977 9
1978 3
1979 6
1980 6
1981 1
1982 2
1983 3
1984 2
1985 3
1986 6
1987 3
1988 5
1989 7
1990 7
1991 5
1992 8
1993 8
1994 9
1995 10
1996 11
1997 5
1998 2
1999 10
2000 11
2001 9
2002 11
2003 11
2004 15
2005 10
2006 7
2007 7
2008 6
2009 9
2010 12
2011 11
2012 10
2013 10
2014 10
2015 8
2016 19
2017 14
2018 12
2019 13
2020 26
2021 31
2022 28
2023 32
2024 34

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

528 results

Results by year

Filters applied: . Clear all
Page 1
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies.
Gauthier J, Bezerra ED, Hirayama AV, Fiorenza S, Sheih A, Chou CK, Kimble EL, Pender BS, Hawkins RM, Vakil A, Phi TD, Steinmetz RN, Jamieson AW, Bar M, Cassaday RD, Chapuis AG, Cowan AJ, Green DJ, Kiem HP, Milano F, Shadman M, Till BG, Riddell SR, Maloney DG, Turtle CJ. Gauthier J, et al. Among authors: jamieson aw. Blood. 2021 Jan 21;137(3):323-335. doi: 10.1182/blood.2020006770. Blood. 2021. PMID: 32967009 Free PMC article. Clinical Trial.
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.
Jamieson A, Huvila J, Chiu D, Thompson EF, Scott S, Salvador S, Vicus D, Helpman L, Gotlieb W, Kean S, Samouelian V, Köbel M, Kinloch M, Parra-Harran C, Offman S, Grondin K, Irving J, Lum A, Senz J, Leung S, McConechy MK, Plante M, Kommoss S, Huntsman DG, Talhouk A, Gilks CB, McAlpine JN. Jamieson A, et al. Mod Pathol. 2023 Apr;36(4):100085. doi: 10.1016/j.modpat.2022.100085. Epub 2023 Jan 25. Mod Pathol. 2023. PMID: 36788084 Free article.
To the editor.
Gilks CB, Jamieson A, McAlpine JN, Singh N. Gilks CB, et al. Among authors: jamieson a. Gynecol Oncol. 2023 Sep;176:179-180. doi: 10.1016/j.ygyno.2023.06.580. Epub 2023 Jul 7. Gynecol Oncol. 2023. PMID: 37423805 No abstract available.
Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas.
Jamieson A, Vermij L, Kramer CJH, Jobsen JJ, Jürgemlienk-Schulz I, Lutgens L, Mens JW, Haverkort MAD, Slot A, Nout RA, Oosting J, Carlson J, Howitt BE, Ip PPC, Lax SF, McCluggage WG, Singh N, McAlpine JN, Creutzberg CL, Horeweg N, Gilks CB, Bosse T. Jamieson A, et al. Clin Cancer Res. 2023 Dec 1;29(23):4949-4957. doi: 10.1158/1078-0432.CCR-23-1397. Clin Cancer Res. 2023. PMID: 37773079 Free PMC article.
Classification of Vulvar Squamous Cell Carcinoma and Precursor Lesions by p16 and p53 Immunohistochemistry: Considerations, Caveats, and an Algorithmic Approach.
Yang H, Almadani N, Thompson EF, Tessier-Cloutier B, Chen J, Ho J, Senz J, McConechy MK, Chow C, Ta M, Cheng A, Karnezis A, Huvila J, McAlpine JN, Gilks B, Jamieson A, Hoang LN. Yang H, et al. Among authors: jamieson a. Mod Pathol. 2023 Jun;36(6):100145. doi: 10.1016/j.modpat.2023.100145. Epub 2023 Feb 22. Mod Pathol. 2023. PMID: 36828360 Free article.
528 results